Entrada Therapeutics, Inc. Stock Performance
as on October 14, 2025 at 1:29 am IST
Day's Low
Day's High
$5.79$6.17
0.17%
Downside
6.38%
Upside
52 Week's Low
52 Week's High
$4.93$21.7915.00%
Downside
275.69%
Upside
Entrada Therapeutics, Inc. share price movements today
- Previous Close
- $6.09
- Open
- $6.17
- Volume
- 180.3K
- Day's Low - High
- $5.79 - $6.17
- 52 Week Low - High
- $4.93 - $21.79
Entrada Therapeutics, Inc. Historical Returns
- 1 Month Return
- + 10.04 %
- 3 Month Return
- -14.56 %
- 1 Year Return
- -67.41 %
- 3 Year Return
- -62.54 %
- 5 Year Return
- 0 %
Entrada Therapeutics, Inc. Stock Fundamentals & Key Indicators
Check Entrada Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$231.6M
EPS (TTM)
-3.38
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
6.23
Industry PE ratio
-0.32286624203821657
PEG Ratio
0EBITDA
-92.3M
Revenue (TTM)
79.5M
Profit Margin
-92.30%
Return On Equity TTM
25131200.00%
Entrada Therapeutics, Inc. Stock Valuation
Track how Entrada Therapeutics, Inc. P/E has moved over time to understand its valuation trends.
Entrada Therapeutics, Inc. in the last 5 years
Lowest (-56.99x)
December 31, 2023
Industry (-0.32x)
October 14, 2025
Today (6.23x)
October 14, 2025
Highest (22.44x)
March 31, 2024
Today’s Price to Earnings Ratio: 6.23x
Entrada Therapeutics, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Entrada Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $231.6M | NA | 6.23 | -92.30% | |
| BUY | $60.3B | 223.08% | -505.15 | -12.96% | |
| NA | $37.8B | NA | NA | -3.89% | |
| BUY | $104.6B | 50.07% | 28.98 | 31.86% | |
| BUY | $59.8B | -7.17% | 14.23 | 31.37% |
Stock Returns calculator for Entrada Therapeutics, Inc. Stock including INR - Dollar returns
The Entrada Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Entrada Therapeutics, Inc. investment value today
Current value as on today
₹38,135
Returns
Returns from Entrada Therapeutics, Inc. Stock
Dollar Returns*
₹5,606 (+5.61%)
Analyst Recommendation on Entrada Therapeutics, Inc. Stock
Based on 10 analysts
90.00%
Buy
10.00%
Hold
0.00%
Sell
Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Entrada Therapeutics, Inc.. Average target price of $18.5
Entrada Therapeutics, Inc. Share Price Target
Get share price movements and forecasts by analysts on Entrada Therapeutics, Inc..
What analysts predicted
68.65%UPSIDE
Target Price
$18.5
Current Price
$5.8
Analyzed by
10 Analysts
Target
$18.50
Entrada Therapeutics, Inc. target price $18.5, a slight upside of 68.65% compared to current price of $5.8. According to 10 analysts rating.
Entrada Therapeutics, Inc. Stock’s Investor Sentiment and Interest
Search interest for Entrada Therapeutics, Inc. Stock has decreased by -39% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Entrada Therapeutics, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Entrada Therapeutics, Inc. Annual Profit & Loss
All numbers in Millions USD
Entrada Therapeutics, Inc. Quarterly Cash Flow
All numbers in Millions USD
Entrada Therapeutics, Inc. Annual Cash Flow
All numbers in Millions USD
Insights on Entrada Therapeutics, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 150.6% return, outperforming this stock by 213.1%
- NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 64.1% return, outperforming this stock by 131.5%
NEGATIVE IMPACTPrice Dip
In the last 6 months, TRDA stock has moved down by -26.6%
About Entrada Therapeutics, Inc.
| Organisation | Entrada Therapeutics, Inc. |
| Headquarters | One Design Center Place, Boston, MA, United States, 02210 |
| Industry | Services |
| CEO | Mr. Dipal Doshi |
| E-voting on shares | Click here to vote |
Key Management of Entrada Therapeutics, Inc.
Name | Title |
|---|---|
Mr. Nathan J. Dowden | President & COO |
Mr. Kory James Wentworth CPA | CFO & Treasurer |
Dr. Jared Cohen J.D., Ph.D. | General Counsel |
Ms. Kerry Robert M.S. | Senior Vice President of People |
Ms. Karla MacDonald | Chief Corporate Affairs Officer |
Mr. Dipal Doshi | CEO & Director |
Dr. Natarajan Sethuraman Ph.D. | President of Research & Development |
Mr. Kevin Healy Ph.D. | Senior Vice President of Regulatory Affairs |
Sandeep Basnet | Head of Information Technology |
FAQs
What is Entrada Therapeutics, Inc. share price today?
Entrada Therapeutics, Inc. share price today is $5.8 as on at the close of the market. Entrada Therapeutics, Inc. share today touched a day high of $6.17 and a low of $5.79.
What is the 52 week high and 52 week low for Entrada Therapeutics, Inc. share?
Entrada Therapeutics, Inc. share touched a 52 week high of $21.79 on and a 52 week low of $4.93 on . Entrada Therapeutics, Inc. stock price today i.e. is closed at $5.8,which is 73.38% down from its 52 week high and 17.65% up from its 52 week low.
What is Entrada Therapeutics, Inc.'s market capitalisation today?
Entrada Therapeutics, Inc. market capitalisation is $0.00T as on .
How to invest in Entrada Therapeutics, Inc. Stock (TRDA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Entrada Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Entrada Therapeutics, Inc. Shares that will get you 0.2586 shares as per Entrada Therapeutics, Inc. share price of $5.8 per share as on October 14, 2025 at 1:29 am IST.
What is the minimum amount required to buy Entrada Therapeutics, Inc. Stock (TRDA) from India?
Indian investors can start investing in Entrada Therapeutics, Inc. (TRDA) shares with as little as ₹88.635 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.35 in Entrada Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Entrada Therapeutics, Inc. share’s latest price of $5.8 as on October 14, 2025 at 1:29 am IST, you will get 1.7241 shares of Entrada Therapeutics, Inc.. Learn more about
fractional shares .